Clinical Trial Update: Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of docetaxel, doxorubicin, and prednisone in patients with advanced prostate cancer that progressed on hormone therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• PREDNISONE (Prednisone)
• Taxotere (docetaxel)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED